- Home
- DAWN vs FSBC Comparison
DAWN vs FSBC Comparison
Compare DAWN & FSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- FSBC
- Stock Information
- Founded
- DAWN 2018
- FSBC 2002
- Country
- DAWN United States
- FSBC United States
- Employees
- DAWN N/A
- FSBC N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- FSBC Banks
- Sector
- DAWN Health Care
- FSBC Finance
- Exchange
- DAWN Nasdaq
- FSBC Nasdaq
- Market Cap
- DAWN 624.8M
- FSBC 628.9M
- IPO Year
- DAWN 2021
- FSBC 2021
- Fundamental
- Price
- DAWN $7.15
- FSBC $32.89
- Analyst Decision
- DAWN Strong Buy
- FSBC Buy
- Analyst Count
- DAWN 7
- FSBC 5
- Target Price
- DAWN $27.86
- FSBC $34.80
- AVG Volume (30 Days)
- DAWN 1.1M
- FSBC 29.3K
- Earning Date
- DAWN 10-29-2025
- FSBC 10-27-2025
- Dividend Yield
- DAWN N/A
- FSBC 2.44%
- EPS Growth
- DAWN N/A
- FSBC 2.40
- EPS
- DAWN N/A
- FSBC 2.44
- Revenue
- DAWN $187,638,000.00
- FSBC $132,133,000.00
- Revenue This Year
- DAWN $12.56
- FSBC $33.14
- Revenue Next Year
- DAWN $48.02
- FSBC $15.40
- P/E Ratio
- DAWN N/A
- FSBC $13.46
- Revenue Growth
- DAWN 2190.50
- FSBC 18.01
- 52 Week Low
- DAWN $5.64
- FSBC $22.22
- 52 Week High
- DAWN $16.76
- FSBC $35.13
- Technical
- Relative Strength Index (RSI)
- DAWN 51.15
- FSBC 60.61
- Support Level
- DAWN $7.03
- FSBC $32.57
- Resistance Level
- DAWN $7.58
- FSBC $33.33
- Average True Range (ATR)
- DAWN 0.27
- FSBC 0.77
- MACD
- DAWN -0.04
- FSBC -0.06
- Stochastic Oscillator
- DAWN 29.55
- FSBC 61.02
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.